Skip to content 
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. The company also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders, including obesity and type 2 diabetes. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California. more
| Time Frame | SEPN | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 8.23% | -1.08% | -1.38% |
| 1-Month Return | 4.25% | -0.47% | -1.81% |
| 3-Month Return | 42.93% | 2.13% | 1.38% |
| 6-Month Return | 135.24% | 17.04% | 5.68% |
| 1-Year Return | 138.1% | 6.56% | 11.74% |
| 3-Year Return | 52.78% | 16.78% | 65.15% |
| Dec '22 | Dec '23 | Dec '24 | ||||
|---|---|---|---|---|---|---|
| Total Revenue | - | 151.00K | 1.07M | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":14.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Cost of Revenue | - | - | - | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | ||
| Gross Profit | - | 151.00K | 1.07M | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":14.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Gross Margin | - | 100.00% | 100.00% | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Operating Expenses | 27.97M | (1.92M) | 81.90M | [{"date":"2022-12-31","value":34.15,"profit":true},{"date":"2023-12-31","value":-2.35,"profit":false},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Operating Income | (27.97M) | 2.08M | (80.82M) | [{"date":"2022-12-31","value":-1347.81,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-3895.08,"profit":false}] | ||
| Total Non-Operating Income/Expense | 582.00K | 5.58M | 17.14M | [{"date":"2022-12-31","value":3.39,"profit":true},{"date":"2023-12-31","value":32.56,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Pre-Tax Income | (27.68M) | 4.87M | (72.30M) | [{"date":"2022-12-31","value":-568.18,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1484.21,"profit":false}] | ||
| Income Taxes | - | 691.00K | (498.00K) | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-72.07,"profit":false}] | ||
| Income After Taxes | - | 4.18M | (71.80M) | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1717.66,"profit":false}] | ||
| Income From Continuous Operations | (27.68M) | 4.18M | (71.80M) | [{"date":"2022-12-31","value":-662.11,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1717.66,"profit":false}] | ||
| Income From Discontinued Operations | - | - | - | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | ||
| Net Income | (27.68M) | 4.18M | (71.80M) | [{"date":"2022-12-31","value":-662.11,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1717.66,"profit":false}] | ||
| EPS (Diluted) | - | - | (18.02) | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-1802,"profit":false}] | ||
These ratios help you determine the liquidity of the company. Higher is better.
| SEPN | |
|---|---|
| Cash Ratio | 6.30 |
| Current Ratio | 6.53 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| SEPN | |
|---|---|
| ROA (LTM) | -14.33% |
| ROE (LTM) | -22.38% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| SEPN | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.36 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.64 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| SEPN | |
|---|---|
| Trailing PE | NM |
| Forward PE | 107.53 |
| P/S (TTM) | 52.32 |
| P/B | 2.97 |
| Price/FCF | 7 |
| EV/R | 31.90 |
| EV/Ebitda | NM |
Septerna, Inc. Common Stock (SEPN) share price today is $27.5
Yes, Indians can buy shares of Septerna, Inc. Common Stock (SEPN) on Vested. To buy
Yes, you can purchase fractional shares of Septerna, Inc. Common Stock (SEPN) via the Vested app. You can start investing in Septerna, Inc. Common Stock (SEPN) with a minimum investment of $1.
You can invest in shares of Septerna, Inc. Common Stock (SEPN) via Vested in three simple steps:
The 52-week high price of Septerna, Inc. Common Stock (SEPN) is $30.5. The 52-week low price of Septerna, Inc. Common Stock (SEPN) is $4.17.
The price-to-earnings (P/E) ratio of Septerna, Inc. Common Stock (SEPN) is
The price-to-book (P/B) ratio of Septerna, Inc. Common Stock (SEPN) is 2.97
The dividend yield of Septerna, Inc. Common Stock (SEPN) is 0.00%
The market capitalization of Septerna, Inc. Common Stock (SEPN) is $1.15B
The stock symbol (or ticker) of Septerna, Inc. Common Stock is SEPN
Consider the share price of Septerna, Inc. Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Septerna, Inc. Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Septerna, Inc. Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Septerna, Inc. Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Septerna, Inc. Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Septerna, Inc. Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
